CLINICAL_TRIALS
trial_result
· 2010-03-25
Clinical Trial Update: 26-week Open Study of telmisartan40mg+amlodipine10mg or telmisartan80mg+amlodipine10 mg in Hypertension [Phase 3]
Summary
A Phase 3 open-label trial compared two telmisartan/amlodipine dose regimens for hypertension; results were posted in 2010.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2010-03-25